FDA grants IDE to SpinaFX for study of Triojection
The planned trial is expected to include 300 participants across two treatment arms.
Analysis
View MoreTracking carbon, tracing change
To track and verify embodied emissions through every stage of the supply chain, leading OEMs are piloting blockchain-anchored digital product passports (DPPs). Ellie Philpotts talks to Chris Taylor, sustainability lead...
Go with the flow
Harnessing automation
How smart can it be?
Killer nanopatterns